Annovis Bio Inc.

ANVS | NYSE

Price Alert Chart Builder DCF Calculator

$1.26

+$0.07 (+5.88%)

Sep 22, 2026, 2:20 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	19.53M	10.55M	5.75M	28.38M	45.69M	8.07M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	7.5K	7.5K	20.8K	7.54M	9.87K	6.44K
Total Current Assets	21.08M	13.93M	10.21M	36.02M	46M	8.12M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a
Total Assets	21.08M	13.93M	10.21M	36.02M	46M	8.12M
Account Payables	2.59M	2.31M	1.29M	3.96M	688.07K	341.86K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	618.66K	1.21M	273	0	105.67K	220.03K
Total Current Liabilities	3.64M	3.88M	4.28M	7.7M	1.51M	578.38K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	595K	737K	13.68M	n/a	n/a	n/a
Total Long-Term Liabilities	595K	737K	13.68M	n/a	n/a	n/a
Total Liabilities	4.23M	4.62M	17.96M	7.7M	1.51M	578.38K
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a
Book Value	16.85M	9.31M	-7.75M	28.32M	44.49M	7.54M
Book Value Per Share	0.82	0.76	-0.86	3.47	5.83	1.20
Common Stock	2.72K	1.41K	1.05K	816	810	689
Retained Earnings	-163.7M	-134.85M	-110.26M	-54.05M	-28.73M	-14.24M
Comprehensive Income	n/a	n/a	n/a	0	n/a	n/a
Shareholders Equity	16.85M	9.31M	-7.75M	28.32M	44.49M	7.54M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a